BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 24039098)

  • 1. Pulmonary interstitial glycogenosis in a patient ultimately diagnosed with Noonan syndrome.
    Ross MK; Ellis LS; Bird LM; Hagood JS
    Pediatr Pulmonol; 2014 May; 49(5):508-11. PubMed ID: 24039098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noonan syndrome: Severe phenotype and PTPN11 mutations.
    Carrasco Salas P; Gómez-Molina G; Carreto-Alba P; Granell-Escobar R; Vázquez-Rico I; León-Justel A
    Med Clin (Barc); 2019 Jan; 152(2):62-64. PubMed ID: 29703613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTPN11 and KRAS gene analysis in patients with Noonan and Noonan-like syndromes.
    Brasil AS; Pereira AC; Wanderley LT; Kim CA; Malaquias AC; Jorge AA; Krieger JE; Bertola DR
    Genet Test Mol Biomarkers; 2010 Jun; 14(3):425-32. PubMed ID: 20578946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation analysis of the genes involved in the Ras-mitogen-activated protein kinase (MAPK) pathway in Korean patients with Noonan syndrome.
    Lee ST; Ki CS; Lee HJ
    Clin Genet; 2007 Aug; 72(2):150-5. PubMed ID: 17661820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary interstitial glycogenosis in the setting of lung growth abnormality: radiographic and pathologic correlation.
    Castillo M; Vade A; Lim-Dunham JE; Masuda E; Massarani-Wafai R
    Pediatr Radiol; 2010 Sep; 40(9):1562-5. PubMed ID: 20440487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PTPN11 analysis for the prenatal diagnosis of Noonan syndrome in fetuses with abnormal ultrasound findings.
    Lee KA; Williams B; Roza K; Ferguson H; David K; Eddleman K; Stone J; Edelmann L; Richard G; Gelb BD; Kornreich R
    Clin Genet; 2009 Feb; 75(2):190-4. PubMed ID: 18759865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent Pulmonary Hypertension Without Underlying Cardiac Disease as a Presentation of Pulmonary Interstitial Glycogenosis.
    Still GG; Li S; Wilson M; Sammut P
    Fetal Pediatr Pathol; 2018 Feb; 37(1):22-26. PubMed ID: 29336713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spectrum of mutations in Noonan syndrome and their correlation with phenotypes.
    Lee BH; Kim JM; Jin HY; Kim GH; Choi JH; Yoo HW
    J Pediatr; 2011 Dec; 159(6):1029-35. PubMed ID: 21784453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary interstitial glycogenosis associated with a spectrum of neonatal pulmonary disorders.
    Cutz E; Chami R; Dell S; Langer J; Manson D
    Hum Pathol; 2017 Oct; 68():154-165. PubMed ID: 28873355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Noonan syndrome: from phenotype to growth hormone therapy].
    Malaquias AC; Ferreira LV; Souza SC; Arnhold IJ; Mendonça BB; Jorge AA
    Arq Bras Endocrinol Metabol; 2008 Jul; 52(5):800-8. PubMed ID: 18797587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary interstitial glycogenosis.
    Lanfranchi M; Allbery SM; Wheelock L; Perry D
    Pediatr Radiol; 2010 Mar; 40(3):361-5. PubMed ID: 19902199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-resolution CT findings of pulmonary interstitial glycogenosis.
    Weinman JP; White CJ; Liptzin DR; Deterding RR; Galambos C; Browne LP
    Pediatr Radiol; 2018 Aug; 48(8):1066-1072. PubMed ID: 29687227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary interstitial glycogenosis: words of caution.
    Deutsch GH; Young LR
    Pediatr Radiol; 2010 Sep; 40(9):1471-5. PubMed ID: 20593171
    [No Abstract]   [Full Text] [Related]  

  • 14. Persistent Tachypnea of Infancy. Usual and Aberrant.
    Rauch D; Wetzke M; Reu S; Wesselak W; Schams A; Hengst M; Kammer B; Ley-Zaporozhan J; Kappler M; Proesmans M; Lange J; Escribano A; Kerem E; Ahrens F; Brasch F; Schwerk N; Griese M;
    Am J Respir Crit Care Med; 2016 Feb; 193(4):438-47. PubMed ID: 26474448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and molecular characterization of 40 patients with Noonan syndrome.
    Ferrero GB; Baldassarre G; Delmonaco AG; Biamino E; Banaudi E; Carta C; Rossi C; Silengo MC
    Eur J Med Genet; 2008; 51(6):566-72. PubMed ID: 18678287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of gene dosage imbalances in patients with Noonan syndrome using multiplex ligation-dependent probe amplification analysis.
    Nyström AM; Ekvall S; Thuresson AC; Denayer E; Legius E; Kamali-Moghaddam M; Westermark B; Annerén G; Bondeson ML
    Eur J Med Genet; 2010; 53(3):117-21. PubMed ID: 20302979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and clinical analysis of RAF1 in Noonan syndrome and related disorders: dephosphorylation of serine 259 as the essential mechanism for mutant activation.
    Kobayashi T; Aoki Y; Niihori T; Cavé H; Verloes A; Okamoto N; Kawame H; Fujiwara I; Takada F; Ohata T; Sakazume S; Ando T; Nakagawa N; Lapunzina P; Meneses AG; Gillessen-Kaesbach G; Wieczorek D; Kurosawa K; Mizuno S; Ohashi H; David A; Philip N; Guliyeva A; Narumi Y; Kure S; Tsuchiya S; Matsubara Y
    Hum Mutat; 2010 Mar; 31(3):284-94. PubMed ID: 20052757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [RAS/MAPK signal transduction pathway and its role in the pathogenesis of Noonan syndrome].
    Gos M; Leszkiewicz M; Abramowicz A
    Postepy Biochem; 2012; 58(3):255-64. PubMed ID: 23373411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid detection by hydrops panel of Noonan syndrome with PTPN11 mutation (p.Thr73Ile) and persistent thrombocytopenia.
    Schönfeld M; Selig M; Russo A; Lindner C; Kampmann C; Mildenberger E; Whybra C
    Mol Genet Genomic Med; 2020 May; 8(5):e1174. PubMed ID: 32144894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two cases of Noonan syndrome with severe respiratory and gastroenteral involvement and the SOS1 mutation F623I.
    Fabretto A; Kutsche K; Harmsen MB; Demarini S; Gasparini P; Fertz MC; Zenker M
    Eur J Med Genet; 2010; 53(5):322-4. PubMed ID: 20673819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.